Therapy (HCV)
"Serum Carnitine Levels in Chronic Hepatitis C Patients Before and After Lymphoblastoid Interferon-alpha Treatment."
Published in Hepatitis Weekly, August 30th, 1999
According to the authors' abstract of an article published in Biodrugs, "Objective: Chronic liver disease is often a hypocarnitinaemic condition. Since carnitine affects lipid metabolism, modifications of lipid pattern and energy metabolism can be expected in patients affected by chronic viral hepatitis. The aim of this study was to assess the relationship between serum carnitine levels and the grading of chronic hepatitis C, and to evaluate the effects of lymphoblastoid interferon (IFN)-alpha n1 on carnitine levels in patients with hepatitis C. Design: We evaluated carnitine serum levels in a group of 32 patients with chronic hepatitis C before and after treatment...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1999-08-30)
More Articles from Hepatitis Weekly
- Genotyping (HCV)
Transient Superinfection Occurs in Some HCV+ Patients - Diagnostics (HCV)
Low-Cost Peptide Test Simplifies HCV Testing - Disease Markers (HCV)
HCV Viremia One Year after Transplant Tied to Fibrosis - Hepatitis Vaccines
Combined Hepatitis A/B Vaccine Shown Effective - Interferon Therapy (HBV)
Mutations Linked to HBV Levels in IFN-Treated Patients - Transmission (HCV)
Study Shows Mother-to-Infant HCV Rare in Africa - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
